Exhaled nitric oxide in asthma: From bench to bedside - 29/08/11
Abstract |
With more than 600 publications, exhaled nitric oxide (NO) has been extensively investigated as a noninvasive marker of airway inflammation in a research setting. This clinical rostrum presents a synopsis of the latest research about this novel marker in asthma and suggests how it might move from bench to bedside. Specifically, we review the evidence citing the applicability of exhaled NO in diagnosing asthma, monitoring the response to therapy, evaluating current symptom control, and predicting exacerbations of asthma. These studies support a role for exhaled NO in the evaluation and treatment of asthma in the clinical arena. (J Allergy Clin Immunol 2003;111:256-62.)
Le texte complet de cet article est disponible en PDF.Keywords : Exhaled, nitric oxide, asthma, monitoring
Abbreviations : AI, AL, BHR, EBC, FENO, LOC, NO, NOS, PPV
Plan
 | Reprint requests: Chris Bates, MD, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206. |
Vol 111 - N° 2
P. 256-262 - février 2003 Retour au numéro
Article précédent
- What are the priorities in basic asthma research? A United Kingdom perspective
- Matthew P. Hallsworth, Philippa J. Major, Jack Barnes, Tak H. Lee
- Asthma control in the Asia-Pacific region: The asthma insights and reality in Asia-Pacific study
- Christopher K.W. Lai, Teresita S. de Guia, You-Young Kim, Sow-Hsong Kuo, Amartya Mukhopadhyay, Joan B. Soriano, Pham Long Trung, Nan Shan Zhong, Norzila Zainudin, B.M.Z. Zainudin, on behalf of the Asthma Insights Reality in Asia-Pacific Steering Committee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?